BEAT - HeartBeam receives patent for ECG smartwatch for detection of heart attacks
- HeartBeam ( NASDAQ: BEAT ) is trading 9% higher after it received patent for a 12-lead electrocardiogram (ECG) smartwatch-based monitor intended for detection of heart attacks and complex cardiac arrhythmias by the U.S. Patent and Trademark Office.
- The company said currently available wearables are not capable of providing a 12-lead ECG for heart attack detection, complex arrhythmia monitoring or other cardiac disorders.
- The global wearables medical device market is estimated to reach $196B by 2030, it added.
For further details see:
HeartBeam receives patent for ECG smartwatch for detection of heart attacks